Really pity those got force selling. Never learn. No money don't buy and don't play contra.

Based on total Q1 to Q3 2023 results. I think total year 2023 profit should be higher than 2022.
Q4 2023 maybe lower than Q3 20238 but still showing profit.

Consolidate all in Sky casino with latest technology and machine. Each old machines need to pay high gambling tax.

Still no results.

Maybe LKT wanted to push the price down and accumulate more before TauRX announcement.

@AngTayKor...when do you think TauRX could get approval ? In a year or more than 2 years

When GenB results?

Just wait for Q4 results. Wait until March 2024 TauRX presentation.
Then only decide buy or sell.

Anyone got GenB results please immediately share.

We are now playing Blackjack casino game.
LKT is the Banker and we are the players.
Picture, Picture, Picture

GenP and GenB result when ? both today ?

Monday ???????????
See how....maybe U Turn.

Today everyone follow selling ?
Tomorrow up everyone chasing without thinking.
the game never end.

Genting Malaysia share price still ok.
Genting Berhad force selling. If you don't have money to pick-up, please don't buy.
It is very painful under force selling by broker.

March 2024 TauRX presentation is just a dream. May the dream come true.

Those bought recently with high trading volume got burn badly.
Why selling at a loss. Cutting loss is not a good habits. You will never win.

WTF - LKT

Today after 5pm we will know Genting Singapore result.

Forget about history.
Looking forward to latest result. Tomorrow Genting Singapore result very important.

Apa lah....2018 old news.

Breaking RM5 is very important. Once break all the way up to RM5.50 then RM6

Genting Singapore result should be out soon. Expect very good.....in Singapore dollars.
Once GenS out, breaking RM5.30 no problem.

This year is WOOD DRAGON.
Genting is on top of the hill with a lot of trees and Wood.
This year is going to be very ONG for Genting Berhad.

Good luck. Just hope for the best and pray that TauRX could bring a fortune this year. So hold tight tight.

Maybe that time he needs money for Genting HK.

If next week GenS or GenP result is very good, Share price sure go up.
Exchange rate convert to Ringgit profit even more for GenB.

According to bursa, if the bosses or any major shareholder is selling, Genting Berhad need to provide detail to bursa and will appear in daily bursa news. So far I didn't see any change of shareholders new in Bursa for a very long times.,

Hold until March 2024.
Genting Bhd’s TauRx Pharmaceuticals’ Alzheimer drugs, which are set to release two years of its Phase Three trial data in March, are also key re-rating catalysts.”
TauRx’s HMTM Phase Three trial may set a milestone towards securing authorities’ approval

More good news and no bad news. Why selling. Should start accumulate. No problem breaking RM5.

https://www.thestar.com.my/business/business-news/2024/02/19/better-gaming-earnings-forecast-for-4q23

Better gaming earnings forecast for 4Q23
“For the casino segment, both Resorts World Genting (RWG) and Resorts World Sentosa (RWS) were packed with visitors queuing to enter the casinos and placing bets during the first week of CNY.

It said the Genting Group is a direct beneficiary of the tourism ramp-up in 2024 with foreign tourist arrivals to Malaysia expected to exceed 2019’s level.

“Positive developments of Genting Malaysia Bhd’s downstate New York’s full-fledged casino licence bid and Genting Bhd’s TauRx Pharmaceuticals’ Alzheimer drugs, which are set to release two years of its Phase Three trial data in March, are also key re-rating catalysts.”

The moratorium for New York’s downstate casino had ended in 2023, and Genting Malaysia’s Resorts World New York City (RWNYC) appeals as one of the frontrunners to secure a full-scale gaming licence.

“We anticipate more newsflow to be released within the first half of 2024 and RWNYC eventually securing a concession which may lift Genting Malaysia’s earnings before interest, taxes, depreciation, and amortisation by US$106mil based on our earlier assumptions,” said UOBKH Research.

On Genting’s 20.33%-owned TauRx, it said positive data from TauRx’s HMTM Phase Three trial may set a milestone towards securing authorities’ approval, which could potentially fetch RM3.45 per share monetisation value for Genting’s stake in TauRx.

The research firm said this was based on assumptions that TauRX was initially eyeing a Nasdaq initial public offering in 2017 with a potential valuation of US$15bil. However, it said it had yet to impute any option value from TauRX.

Aaron Kwok 4 shows in Genting Highland full house.

Slow and steady.
Breaking RM5 soon.

https://theedgemalaysia.com/node/701095

Another notable mention is Genting Bhd. After a flat 2023, analysts have raised the annual earnings forecast for the group for 2023 to 2025, with more upside projected in tourism recovery in markets it operates in, such as Singapore and the US. Consensus TP suggests an upside of 20.2%, compared to its last close of RM4.88, which is down 4% from a year ago.

https://theedgemalaysia.com/node/701095

These are the stocks analysts favour for 2024.
Gamuda, TM, YTLP, Genting top big-cap picks.

Genting top big-cap picks
Among companies with a market capitalization above RM10 billion, conglomerate Gamuda Bhd tops the list with an overwhelming 20 'buy' calls out of 21 analysts. Analysts cite Gamuda's healthy overseas expansion progress, and their consensus TP of RM5.58 represents 8.3% upside against the stock's Feb 15 close of RM5.15. The counter has risen over 29.7% in the last year.

To all Genting Berhad share holders, Happy and Prosperous New Year. May the year begin with TauRX approval and breaking RM8.00.

Crazy force selling.

1st round Poker game 4.80 to 4.83 all gone.
2nd round Poker game 4.84 - 4.86....waiting

Poker game.
Catching weak holders.....loser.

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company will present the 24-month data from its Phase III LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the upcoming AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference from 5-9 March 2024, in Lisbon, Portugal.

TauRx has initiated regulatory engagement in the UK and the US for intended product approval. Other territories will follow in line with plans to scale commercialisation of HMTM.

The future of Genting Berhad - TauRX.

Once Taurx approved.......TP RM8.00.
Pray hard hard to God of Heaven on the Seven day of Chinese New Year.

Genting Singapore - Ex rate - RM3.54
Genting US - Ex rate - RM4.76
Genting England - Ex rate - RM5.97

More Profit when convert to Ringgit Malaysia.

Normally Genting Singapore will announce result a day earlier than GenB.
Once GenS result announce, share price could break RM5 if result very good.
Singapore dollars 3.54 could result more profit to GenB.

Believe in yourself.
If you think the future revenue and profit is going to be good for long run, then buy.

Good luck. Happy and Prosperous Chinese new year to all Genting Berhad share holders.

19 years ago ?

According to my broker, A lot bought from him more than RM10 and is still holding.

Just wait until Q4 2023 and total 2023 results. Normally Genting Singapore results out first, should be very good. The share price should go up until GenB results announcement. Hopefully dividend better than last year.

https://www.nst.com.my/business/corporate/2024/01/1002661/resorts-world-sentosa-operator-may-bid-casino-licence-tap-influx

Resorts World Sentosa operator may bid for casino licence to tap influx of foreign tourists.

KUALA LUMPUR: Genting Singapore, the operator of Resorts World Sentosa, may likely be the front-runner to secure a license for an integrated resort (IR) and casino in Thailand if the Thai government decides to deregulate the industry, according to analysts.

can we get more than 10 cents of dividend ?

If China first to approved TauRX, others will follow. Then GenB share sure fly high. Hold tight tight.